DUOGLOBE: One-Year Outcomes in a Real-World Study of Levodopa Carbidopa Intestinal Gel for Parkinson's Disease.
David G StandaertJason AldredMarieta Anca-HerschkovitschPaul BourgeoisEsther CuboThomas L DavisRobert IansekNorbert KovácsFrancesco Ernesto PontieriMustafa S SiddiquiMihaela SimuLars BergmannPavnit KukrejaWeining Z RobiesonKallol Ray ChaudhuriPublished in: Movement disorders clinical practice (2021)
These 12-month outcome data show sustained, long-term improvements and support the real-world effectiveness of LCIG in patients with advanced PD. Safety was consistent with previous studies.